AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 94 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q3 2015. The put-call ratio across all filers is 2.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $6,591,000 | +13.2% | 692,294 | -2.1% | 0.03% | +20.8% |
| Q3 2015 | $5,824,000 | +82.8% | 706,846 | +260.3% | 0.02% | +84.6% |
| Q2 2015 | $3,186,000 | -48.5% | 196,185 | +28.5% | 0.01% | -48.0% |
| Q1 2015 | $6,185,000 | +163.2% | 152,651 | +250.7% | 0.02% | +177.8% |
| Q4 2014 | $2,350,000 | – | 43,524 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,382,735 | $73,076,000 | 20.10% |
| Redmile Group, LLC | 699,070 | $37,750,000 | 4.11% |
| Ghost Tree Capital, LLC | 125,000 | $6,750,000 | 3.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,614,669 | $87,192,000 | 3.13% |
| Green Owl Capital Management, LLC | 26,000 | $1,404,000 | 1.26% |
| COWEN INC. | 248,674 | $13,428,000 | 1.06% |
| RTW INVESTMENTS, LP | 50,000 | $2,700,000 | 1.00% |
| Cormorant Asset Management, LP | 65,000 | $3,510,000 | 0.54% |
| Tourbillon Capital Partners, L.P. | 330,000 | $17,820,000 | 0.48% |
| QVT Financial LP | 108,000 | $5,832,000 | 0.29% |